Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

Tamoxifen is the standard-of-care treatment for estrogen receptor-positive premenopausal breast cancer. We examined tamoxifen metabolism via blood metabolite concentrations and germline variations of CYP3A5, CYP2C9, CYP2C19 and CYP2D6 in 587 premenopausal patients (Asians, Middle Eastern Arabs, Cauc...

Full description

Bibliographic Details
Main Authors:	Saladores, P. (Author), Mürdter, T. (Author), Eccles, Diana (Author), Chowbay, B. (Author), Zgheib, N.K (Author), Winter, S. (Author), Ganchev, B. (Author), Eccles, Bryony (Author), Gerty, Sue (Author), Tfayli, A. (Author), Lim, J.S.L (Author), Yap, Y.S (Author), Ng, R.C.H (Author), Wong, N.S (Author), Dent, R. (Author), Habbal, M.Z (Author), Schaeffeler, E. (Author), Eichelbaum, M. (Author), Schroth, W. (Author), Schwab, M. (Author), Brauch, H. (Author)
Format:	Article
Language:	English
Published:	2015.
Subjects:	Article
Online Access:	Get fulltext

Similar Items

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
by: Werner Schroth, et al.
Published: (2017-08-01)

Clinical Trial: CYP2D6 Related Dose Escalation of Tamoxifen in Breast Cancer Patients With Iranian Ethnic Background Resulted in Increased Concentrations of Tamoxifen and Its Metabolites
by: Zahra Khalaj, et al.
Published: (2019-05-01)

Effect of Tamoxifen and Raloxifene on the Proliferative Activity of the Breast Epithelium in Premenopausal Women
by: Miliana T. Lucato, et al.
Published: (2015-01-01)

Effect of Tamoxifen and Raloxifene on the Proliferative Activity of the Breast Epithelium in Premenopausal Women
by: Miliana T. Lucato, et al.
Published: (2015-03-01)

Impact of estrogen deprivation on bone health in premenopausal women treated with tamoxifen
by: Filipa Isabel Lima Coelho
Published: (2019)

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
by: Mikael Eriksson, et al.
Published: (2021-01-01)

Study of the action of tamoxifen on the mammary gland epithelium of premenopausal patients by lysosome quantification
by: Carlos ltio Tanaka, et al.

Tamoxifen Effects on the lipid profile in premenopausal women with Breast cancer: A follow up study
by: Zainab A. M. Ali, et al.
Published: (2018-12-01)

The clinical and pathological characteristics of breast cancer in young women and implications for genetic testing
by: Eccles, Bryony
Published: (2015)

Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials
by: Yan S, et al.
Published: (2015-06-01)

Mammographic density change in a cohort of premenopausal women receiving tamoxifen for breast cancer prevention over 5 years
by: Adam R. Brentnall, et al.
Published: (2020-09-01)

Ovarian hyperstimulation syndrome followed by ovarian torsion in premenopausal patient using adjuvant tamoxifen treatment for breast cancer
by: Behnaz Moradi, et al.
Published: (2016-09-01)

Addition of Adjuvant Tamoxifen to Cyclophosphamide, Methotrexate and 5-Fluorouracil for Premenopausal Women with Oestrogen Receptor-Positive Breast Cancer
by: He-Cheng Li, et al.
Published: (2003-07-01)

A prospective, randomized study of Toremifene vs. tamoxifen for the treatment of premenopausal breast cancer: safety and genital symptom analysis
by: Jin Hong, et al.
Published: (2020-07-01)

The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)‐Endoxifen in Breast Cancer
by: Jeanine Marie Nardin, et al.
Published: (2020-03-01)

By the Metrics Surgical Oophorectomy Plus Tamoxifen is the First Adjuvant Treatment Option for Premenopausal Women with Hormone Receptor Positive Breast Cancer
by: Richard Love
Published: (2021-01-01)

Estudo da atividade hormonal de mulheres tratadas com tamoxifeno no menacme A study of hormone activity in premenopausal tamoxifen-treated women
by: Júlio Roberto de M. Bernardes Jr, et al.
Published: (1998-10-01)

Genotoxicity of tamoxifen and structural analogues of tamoxifen : studies on the activation of tamoxifen by cytochrome P450s and peroxidase
by: Davies, Adrian M.
Published: (1999)

Premenopausal osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2013-01-01)

Premenopausal Vaginitis
by: Walter, K.
Published: (2022)

Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
by: Thomas Helland, et al.
Published: (2021-04-01)

Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
by: Anna Mueller-Schoell, et al.
Published: (2021-02-01)

Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
by: Anna Mueller-Schoell, et al.
Published: (2021-05-01)

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial
by: Li J, et al.
Published: (2018-12-01)

Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
by: Christine Lundgren, et al.
Published: (2020-12-01)

Contraception in premenopausal women
by: Y. E. Dobrokhotova, et al.
Published: (2015-12-01)

A prospective study of the effects of frequent infection on the energy metabolism of Gambian infants
by: Eccles, M.
Published: (1987)

Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study
by: Rena Yamazaki, et al.
Published: (2020-01-01)

A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study
by: Gu Ran, et al.
Published: (2012-05-01)

Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
by: Zhen-Yu Wu, et al.
Published: (2021-04-01)

MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN
by: S. N. Tolstov, et al.
Published: (2011-12-01)

Uterine fibroids in premenopausal women
by: Yu. E. Dobrokhotova, et al.
Published: (2019-10-01)

Information required for surgical decision making in young women with breast cancer
by: Recio, Alejandra, et al.
Published: (2013)

Applications of Geographic Information Systems in Landscape Ecotoxicology
by: Eccles, Kristin M.
Published: (2019)

A validation of the Joint Army/Navy Rotorcraft Analysis and Design software by comparison with H-34 and UH-60A flight test
by: Eccles, David M.
Published: (2013)

Automated Pictorial Analysis of Muscle Fibres and other Biological Material
by: Eccles, M. J.
Published: (1977)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
by: Yuntao Wang MS, et al.
Published: (2021-03-01)

Mammary gland condition in premenopausal women with endometrial hyperplasia
by: Y. E. Dobrokhotova, et al.
Published: (2021-04-01)

Structural and functional parameters of the vascular bed in premenopausal hypertensive women
by: Marina Mikhaylovna Khabibulina, et al.
Published: (2011-12-01)

Biomarkers of mammographic density in premenopausal women
by: Mathilde His, et al.
Published: (2021-07-01)